Trial intelligence / Profile preview

FOLFOX4 in Resectable Colorectal Liver Metastasis

NCT01035385Phase 3Unknown

Sponsor
Guangdong Provincial People's Hospital
Start
Sep 2009
Primary completion
Oct 2012
Modality
DNA Intercalators/Alkylators, Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of oxaliplatin, folinic acid, fluorouracil in colorectal cancer (CRC), liver metastasis, sponsored by Guangdong Provincial People's Hospital. Status: unknown.

02

Drugs

oxaliplatinfolinic acidfluorouracil
03

Conditions

colorectal cancer (CRC)liver metastasis

Beyond the preview

Go deeper on NCT01035385.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01035385.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call